PowerSchool to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
FOLSOM, Calif.–(BUSINESS WIRE)–PowerSchool Holdings, Inc. (NYSE: PWSC) (“PowerSchool” or the “Company”), the leading provider of…
FOLSOM, Calif.–(BUSINESS WIRE)–PowerSchool Holdings, Inc. (NYSE: PWSC) (“PowerSchool” or the “Company”), the leading provider of…
FOLSOM, Calif.–(BUSINESS WIRE)–PowerSchool Holdings, Inc. (NYSE: PWSC) (“PowerSchool” or the “Company”), the leading provider of…
Reaffirming commitment to developing next-gen identity authentication solutions SEATTLE–(BUSINESS WIRE)–#authenticid—AuthenticID, a global leader in identity…
Reaffirming commitment to developing next-gen identity authentication solutions SEATTLE–(BUSINESS WIRE)–#authenticid—AuthenticID, a global leader in identity…
Commitment to customer success highlighted by winning all three awards in the ABM software category…
Commitment to customer success highlighted by winning all three awards in the ABM software category…
Industry-Leading initiative continues to provide opportunities for clients and agencies to engage with diversely-owned media…
Industry-Leading initiative continues to provide opportunities for clients and agencies to engage with diversely-owned media…
New Solution Offers Unmatched Backup and Recovery for Power BI Users COPENHAGEN, DENMARK – February…
Award further establishes STACK as prominent safety innovator in the digital infrastructure industry Denver, COLORADO…
CARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,”…
CARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,”…
BASKING RIDGE, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
BASKING RIDGE, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
CARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage…
CARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage…
Glen Rock, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI)…
Glen Rock, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI)…
Bagsværd, Denmark, 1 February 2023 – Novo Nordisk A/S has filed its Annual Report 2022…
Bagsværd, Denmark, 1 February 2023 – Novo Nordisk A/S has filed its Annual Report 2022…